Phathom Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHAT and other ETFs, options, and stocks.About PHAT
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
PHAT Key Statistics
Stock Snapshot
Phathom Pharmaceuticals(PHAT) stock is priced at $6.99, giving the company a market capitalization of 561.45M. It carries a P/E multiple of -5.43.
On 2026-10-05, Phathom Pharmaceuticals(PHAT) stock traded between a low of $6.82 and a high of $7.26. Shares are currently priced at $6.99, which is +2.5% above the low and -3.7% below the high.
Phathom Pharmaceuticals(PHAT) shares are trading with a volume of 1.68M, against a daily average of 1.27M.
During the past year, Phathom Pharmaceuticals(PHAT) stock moved between $6.82 at its lowest and $18.31 at its peak.
During the past year, Phathom Pharmaceuticals(PHAT) stock moved between $6.82 at its lowest and $18.31 at its peak.
PHAT News
...
Phathom Pharmaceuticals ( (PHAT) ) has shared an update. On September 29, 2026, Phathom Pharmaceuticals began patient screening in its pHalcon-NERD-302 registr...
Phathom Pharmaceuticals (PHAT) announced the initiation of patient screening in pHalcon-NERD-302, a registrational Phase 3 study evaluating an as-needed investi...
Analyst ratings
82%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.